Quote | BeiGene Ltd. (NASDAQ:BGNE)
|Last Trade Date Time:||10/02/2023 03:00:00 am|
News | BeiGene Ltd. (NASDAQ:BGNE)
2023-09-24 22:33:00 ET Summary Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a deal worth $132.5 million. Once again, a big pharma has returned partnership rights for BeiGene...
2023-09-19 06:58:00 ET More on BeiGene, Novartis, etc. Sales Success Comes With Side Effects For Drug Maker BeiGene Novartis: Q2 Beats Expectations, But Still Pricey Novartis: Strong Growth And Continued Expansion For KISQALI Novartis shareholders approve 100...
Message Board Posts | BeiGene Ltd. (NASDAQ:BGNE)
|BGNE having a nice bounce and a good,||MiamiGent||investorshub||07/05/2023 7:28:03 PM|
|Thoughts on where this is headed?||StockLearner2011||investorshub||07/03/2023 9:49:33 PM|
|Found an interesting article||luke424||investorshub||06/30/2023 1:45:08 AM|
|$BGNE must see||StockLearner2011||investorshub||06/28/2023 1:49:55 AM|
|here we go bulls news is here||StockLearner2011||investorshub||06/22/2023 3:12:55 PM|
BeiGene Ltd. Company Name:
BGNE Stock Symbol:
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916. Digital Transformation Opportunities Corp. (NASDAQ: DTOC) rose 100.7% t...
Bloomberg Amazon Poaches Microsoft's Product Chief Ahead Of Its Annual Devices Event After Microsoft Corp (NASDAQ: MSFT) Chief Produ...
BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, fr...